Essayan DM, Cyclic nucleotide phosphodiesterases, in J. Allergy Clin. Immunol., vol. 108, n. 5, novembre 2001, pp. 671-80, DOI: ... the effects of non-specific phosphodiesterase inhibition, in Clinics (Sao Paulo), vol. 63, n. 3, giugno 2008, pp. 321-8, PMC ... 671-3, PMID 1971502. ^ Hendeles L, Weinberger M, Milavetz G, Hill M, Vaughan L, Food-induced "dose-dumping" from a once-a-day ... 174, n. 2, gennaio 2005, pp. 589-94, PMID 15634873. ^ Ito K, Lim S, Caramori G, et al., A molecular mechanism of action of ...
... cyclic nucleotide 3-phosphodiesterase harbors a GTP/ATP binding site 1-gen-2007 Masullo, Mariorosario; Arcone, Rosaria ... phosphodiesterase harbors a GTP/ATP binding site. 2007-01-01 Masullo, Mariorosario; Arcone, Rosaria ... Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento ... The N-terminal domain of 2,3-cyclic nucleotide 3- ...
Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World J Urol 1997;15: 32_5.. 29. Boolell M, Allen MJ, ... Kotera J, Sasaki T, Omori K. Recent progress in cyclic nucleotide phosphodiesterase research: isozymes, functions, and ... 30) LUGNIER, C., BERTRAND, Y. & STOCLET, J.C. (1972). Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle ... Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, a1-adrenoceptor and benzothiazepine binding site at the ...